Landmark findings from a major malaria clinical trial led by Menzies School of Health Research (Menzies) and international ...

A higher dose of a primaquine-based regimen was more effective at preventing relapses of Plasmodium vivax malaria than the currently recommended regimen, a randomized trial found. More patients ...

Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in malaria endemic countries. Led by ...

A new study led by Menzies School of Health Research has provided further insight into the cost-effectiveness of a new malaria medication, tafenoquine, to treat vivax malaria. Researchers used a ...